- Home
- BFRI vs JCSE Comparison
BFRI vs JCSE Comparison
Compare BFRI & JCSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRI
- JCSE
- Stock Information
- Founded
- BFRI 1997
- JCSE 1999
- Country
- BFRI United States
- JCSE Singapore
- Employees
- BFRI N/A
- JCSE N/A
- Industry
- BFRI Biotechnology: Pharmaceutical Preparations
- JCSE Miscellaneous manufacturing industries
- Sector
- BFRI Health Care
- JCSE Consumer Discretionary
- Exchange
- BFRI Nasdaq
- JCSE Nasdaq
- Market Cap
- BFRI 6.2M
- JCSE 5.4M
- IPO Year
- BFRI 2021
- JCSE 2022
- Fundamental
- Price
- BFRI $0.76
- JCSE $1.13
- Analyst Decision
- BFRI Strong Buy
- JCSE
- Analyst Count
- BFRI 1
- JCSE 0
- Target Price
- BFRI $7.00
- JCSE N/A
- AVG Volume (30 Days)
- BFRI 7.3M
- JCSE 43.2K
- Earning Date
- BFRI 11-13-2024
- JCSE 10-30-2024
- Dividend Yield
- BFRI N/A
- JCSE N/A
- EPS Growth
- BFRI N/A
- JCSE N/A
- EPS
- BFRI N/A
- JCSE 0.12
- Revenue
- BFRI $35,358,000.00
- JCSE $14,723,999.00
- Revenue This Year
- BFRI $19.11
- JCSE N/A
- Revenue Next Year
- BFRI $20.16
- JCSE N/A
- P/E Ratio
- BFRI N/A
- JCSE $9.44
- Revenue Growth
- BFRI 5.17
- JCSE N/A
- 52 Week Low
- BFRI $0.61
- JCSE $0.60
- 52 Week High
- BFRI $4.04
- JCSE $2.39
- Technical
- Relative Strength Index (RSI)
- BFRI 43.25
- JCSE 44.40
- Support Level
- BFRI $0.65
- JCSE $1.06
- Resistance Level
- BFRI $0.79
- JCSE $1.25
- Average True Range (ATR)
- BFRI 0.11
- JCSE 0.14
- MACD
- BFRI -0.01
- JCSE -0.01
- Stochastic Oscillator
- BFRI 26.41
- JCSE 14.00
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.
About JCSE JE Cleantech Holdings Limited
JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment range from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. It derives a majority of its revenue from Singapore.